ANTARES PHARMA, INC. Contracts & Agreements
79 Contracts & Agreements
- Business Finance (31 contracts)
- Business Operations (6)
- Human Resources (24)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Real Estate (6)
- Uncategorized (10)
- Agreement and Plan of Merger, dated as of April 12, 2022, by and among Halozyme Therapeutics, Inc., Atlas Merger Sub, Inc., and Antares Pharma, Inc (Filed With SEC on April 13, 2022)
- Employment Agreement effective April 26, 2021 between Antares Pharma, Inc. and Dr. Peter C. Richardson (Filed With SEC on March 3, 2022)
- Asset Purchase Agreement, dated December 15, 2021, by and between Antares Pharma, Inc., Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc., and Assertio Holdings,... (Filed With SEC on March 3, 2022)
- Credit Agreement, dated November 1, 2021, by and among Antares Pharma, Inc., Wells Fargo Bank, National Association, and the lenders from time to time party thereto (Filed With SEC on November 2, 2021)
- Second Amendment to Loan and Security Agreement, dated September 15, 2020, by and among Antares Pharma, Inc., Hercules Capital, Inc., and the several banks and other financial... (Filed With SEC on September 21, 2020)
- Description of Companys Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, attached to this Form 10-K as Exhibit 4.5 (Filed With SEC on March 3, 2020)
- Third Amendment to Lease between Princeton Office Center, LLC and Antares Pharma, Inc., dated May 7, 2019 (Filed With SEC on August 6, 2019)
- Form of Non-Qualified Stock Option Grant Agreement (Filed With SEC on August 6, 2019)
- Form of Restricted Stock Unit Grant Agreement (Filed With SEC on August 6, 2019)
- Form of Performance Stock Unit Grant Agreement (Filed With SEC on August 6, 2019)
- Form of Non-Qualified Stock Option Grant Agreement (Non-Employee Directors) (Filed With SEC on August 6, 2019)
- Form of Restricted Stock Unit Grant Agreement (Non-Employee Directors) (Filed With SEC on August 6, 2019)
- Lease Agreement, dated July 1, 2019, by and between Antares Pharma, Inc. and Whitewater Properties I, LLC (Filed With SEC on July 5, 2019)
- First Amendment to Loan and Security Agreement, dated June 26, 2019, by and among Antares Pharma, Inc., Hercules Capital, Inc., and the several banks and other financial... (Filed With SEC on June 27, 2019)
- Form of Indemnification Agreement between Antares Pharma, Inc. and each of its directors and executive officers (Filed With SEC on March 12, 2019)
- Employment Agreement dates as of August 6, 2018 between Antares Pharma, Inc. and James P. Tursi, M.D (Filed With SEC on November 6, 2018)
- ANTARES PHARMA, INC. $30,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on August 11, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on June 7, 2017)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2016)
- ANTARES PHARMA, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2016)
- CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF ANTARES PHARMA, INC. (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTION GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN RESTRICTED STOCK UNIT GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN RESTRICTED STOCK GRANT AGREEMENT (Filed With SEC on August 9, 2016)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2016)
- SEPARATION AND CONSULTING SERVICES AGREEMENT (Filed With SEC on March 8, 2016)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 10, 2015)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)
- ANTARES PHARMA, INC. 2008 EQUITYCOMPENSATION PLAN RESTRICTED STOCK UNIT GRANT AGREEMENT (Filed With SEC on August 10, 2015)
- 20,000,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 6, 2015)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)
- ANTARES PHARMA, INC. 2008EQUITY COMPENSATION PLAN (Filed With SEC on August 7, 2014)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2014)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 7, 2014)
- ANTARES PHARMA, INC. SEVERANCE PLAN and SUMMARY PLAN DESCRIPTION (Filed With SEC on August 7, 2014)
- THE COMPANY HAS APPLIED FOR CONFIDENTIAL TREATMENT OF CERTAIN PROVISIONS OF THIS EXHIBIT WITH THE SECURITIES AND EXCHANGE COMMISSION. THECONFIDENTIAL PORTIONS OF THIS EXHIBIT ARE... (Filed With SEC on August 7, 2014)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 13, 2014)
- TABLE OF CONTENTS (Filed With SEC on March 13, 2014)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT (Filed With SEC on August 7, 2013)
- AMENDMENT 2012-1 TO SENIOR MANAGEMENT AGREEMENT (Filed With SEC on March 13, 2013)
- AMENDMENT 2012-1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2013)
- AMENDMENT 2012-1 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2013)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 13, 2013)
- 12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 4, 2012)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT (Filed With SEC on July 12, 2012)
- ANTARES PHARMA, INC. EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2012)
- PRINCETON SOUTH CORPORATE CENTER OFFICE LEASE Between PRINCETON SOUTH INVESTORS, LLC (a Delaware limited liability company) as Landlord -and- (Filed With SEC on March 12, 2012)
- ANTARES PHARMA, INC. 2008 EQUITY COMPENSATION PLAN PERFORMANCE STOCK UNIT SUMMARY OF GRANT (Filed With SEC on May 23, 2011)
- 12,500,000 Shares ANTARES PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 13, 2011)
- ANTARES PHARMA, INC. PAUL WOTTON AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2011)
- FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on March 14, 2011)
- COMMON STOCK AND WARRANT PURCHASE AGREEMENT by and among Antares Pharma, Inc. and the parties named herein on Schedule 1, as Purchasers June 29, 2007 (Filed With SEC on July 2, 2007)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 2, 2007)
- COMMON STOCK PURCHASE WARRANT To Purchase [35% Coverage] Shares of Common Stock of ANTARES PHARMA, INC. (Filed With SEC on July 2, 2007)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 2, 2007)
- ANTARES PHARMA, INC. (Filed With SEC on March 2, 2007)
- ANTARES PHARMA, INC. (Filed With SEC on March 2, 2007)
- CREDIT FACILITIES (Filed With SEC on March 2, 2007)
- WITNESSETH: (Filed With SEC on August 14, 2006)
- ANTARES PHARMA, INC. 2006 EQUITY INCENTIVE PLAN (Filed With SEC on May 9, 2006)
- LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on March 20, 2006)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 20, 2006)
- COMMON STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 20, 2006)
- INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 20, 2006)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 20, 2006)
- SENIOR MANAGEMENT AGREEMENT BY AND BETWEEN (Filed With SEC on February 14, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 15, 2005)
- ANTARES PHARMA, INC. (Filed With SEC on August 13, 2004)
- PURCHASE AGREEMENT (Filed With SEC on February 10, 2004)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 10, 2004)
- ANTARES PHARMA, INC (Filed With SEC on February 10, 2004)
- CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ANTARES... (Filed With SEC on September 18, 2003)
- Warrant Agreement (Filed With SEC on September 18, 2003)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 18, 2003)
- IMPORTANT: PLEASE READ CAREFULLY BEFORE SIGNING SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN INVESTMENT LETTER (Filed With SEC on September 15, 2003)
- SECURITIES EXCHANGE AGREEMENT (Filed With SEC on September 15, 2003)
- FORM OF LIEN RELEASE AUTHORIZATION LETTER (Filed With SEC on September 15, 2003)